-
1
-
-
0003974187
-
-
Geneva, Switzerland: World Health Organization
-
Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva, Switzerland: World Health Organization, 1988.
-
(1988)
Smallpox and Its Eradication
-
-
Fenner, F.1
Henderson, D.A.2
Arita, I.3
Jezek, Z.4
Ladnyi, I.D.5
-
2
-
-
33744979223
-
-
Washington, DC: US Department of Health, Education, and Welfare, Public Health Service, National Office of Vital Statistics
-
US Department of Health, Education, and Welfare. Vital statistics - special report, national summaries: reported incidence of selected notifiable diseases, United States, each division and state, 1920-50. Washington, DC: US Department of Health, Education, and Welfare, Public Health Service, National Office of Vital Statistics, 1953:37.
-
(1953)
Vital Statistics - Special Report, National Summaries: Reported Incidence of Selected Notifiable Diseases, United States, Each Division and State, 1920-50
, pp. 37
-
-
-
3
-
-
0004328797
-
-
Washington, DC: US Department of Health, Education, and Welfare, Public Health Service, National Center for Health Statistics
-
US Department of Hearth, Education, and Welfare. Vital statistics rates in the United States, 1940-1960. Washington, DC: US Department of Health, Education, and Welfare, Public Health Service, National Center for Health Statistics, 1968.
-
(1968)
Vital Statistics Rates in the United States, 1940-1960
-
-
-
6
-
-
0033554981
-
Recommended childhood immunization schedule - United States, 1999
-
CDC. Recommended childhood immunization schedule - United States, 1999. MMWR 1999; 48:12-6.
-
(1999)
MMWR
, vol.48
, pp. 12-16
-
-
-
7
-
-
0041978837
-
-
Arlington, Virginia: Batelle
-
Batelle Medical Technology Assessment and Policy Reserach Program, Centers for Public Health Research and Evaluation. A cost benefit analysis of the measles-mumps-rubella (MMR) vaccine. Arlington, Virginia: Batelle, 1994.
-
(1994)
A Cost Benefit Analysis of the Measles-mumps-rubella (MMR) Vaccine
-
-
-
8
-
-
0003389793
-
Haemophilus influenzae type b
-
Evans AS, Brachman PS, eds. New York, New York: Plenum Medical Book Co.
-
Cochi SL, Ward JI. Haemophilus influenzae type b. In: Evans AS, Brachman PS, eds. Bacterial infections of humans. New York, New York: Plenum Medical Book Co., 1991
-
(1991)
Bacterial Infections of Humans
-
-
Cochi, S.L.1
Ward, J.I.2
-
9
-
-
0019619642
-
Annual summary 1980: Reported morbidity and mortality in the United States
-
CDC. Annual summary 1980: reported morbidity and mortality in the United States. MMWR 1981;29.
-
(1981)
MMWR
, vol.29
-
-
-
10
-
-
0042479490
-
Reported incidence of notifiable diseases in the United States, 1960
-
CDC. Reported incidence of notifiable diseases in the United States, 1960. MMWR 1961;9.
-
(1961)
MMWR
, vol.9
-
-
-
11
-
-
0042479492
-
Reported morbidity and mortality in the United States, 1970
-
CDC. Reported morbidity and mortality in the United States, 1970. MMWR 1971;19.
-
(1971)
MMWR
, vol.19
-
-
-
12
-
-
0041978836
-
Provisional cases of selected notifiable diseases. United States, cumulative, week ending January 2, 1999 (52nd week)
-
CDC. Provisional cases of selected notifiable diseases. United States, cumulative, week ending January 2, 1999 (52nd week). MMWR 1999;47:1125.
-
(1999)
MMWR
, vol.47
, pp. 1125
-
-
-
13
-
-
0041477685
-
Provisional cases of selected notifiable diseases preventable by vaccination, United States, weeks ending January 2, 1999, and December 27, 1997 (52nd week)
-
CDC. Provisional cases of selected notifiable diseases preventable by vaccination, United States, weeks ending January 2, 1999, and December 27, 1997 (52nd week). MMWR 1999; 47:1128-9.
-
(1999)
MMWR
, vol.47
, pp. 1128-1129
-
-
-
14
-
-
0042479489
-
-
Arlington, Virginia: Batelle
-
Batelle Medical Technology Assessment and Policy Research Program, Centers for Public Health Research and Evaluation. A cost benefit analysis of the OPV vaccine. Arlington, Virginia: Batelle, 1994.
-
(1994)
A Cost Benefit Analysis of the OPV Vaccine
-
-
-
15
-
-
0032503754
-
National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 1997
-
CDC. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 1997. MMWR 1998;47:547-54.
-
(1998)
MMWR
, vol.47
, pp. 547-554
-
-
-
16
-
-
0028767688
-
Certification of poliomyelitis eradication - The Americas, 1994
-
CDC. Certification of poliomyelitis eradication - the Americas, 1994. MMWR 1994;43:720-2.
-
(1994)
MMWR
, vol.43
, pp. 720-722
-
-
-
17
-
-
0031592417
-
Paralytic poliomyelitis - United States, 1980-1994
-
CDC. Paralytic poliomyelitis - United States, 1980-1994. MMWR 1997;46:79-83.
-
(1997)
MMWR
, vol.46
, pp. 79-83
-
-
-
18
-
-
0030941729
-
Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children metropolitan Atlanta, 1985-1987
-
Yeargin-Allsopp M, Murphy CC, Cordero JF, Decoufle P, Hollowell JG. Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children metropolitan Atlanta, 1985-1987. Developmental Medicine and Neurology 1997;39:142-9.
-
(1997)
Developmental Medicine and Neurology
, vol.39
, pp. 142-149
-
-
Yeargin-Allsopp, M.1
Murphy, C.C.2
Cordero, J.F.3
Decoufle, P.4
Hollowell, J.G.5
|